{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:26:53Z","timestamp":1740115613118,"version":"3.37.3"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hungarian Brain Research Program","award":["KTIA_13_NAP-A-II\/18"],"award-info":[{"award-number":["KTIA_13_NAP-A-II\/18"]}]},{"name":"European Union and the State of Hungary"},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"crossref"}]},{"name":"J\u00e1nos Bolyai Research Scholarship of the Hungarian Academy of Sciences"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.bbr.2016.07.021","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T20:46:56Z","timestamp":1468702016000},"page":"272-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Lack of age-related clinical progression in PGC-1\u03b1-deficient mice \u2013 implications for mitochondrial encephalopathies"],"prefix":"10.1016","volume":"313","author":[{"given":"Levente","family":"Szalardy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mate","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Torok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denes","family":"Zadori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laszlo","family":"Vecsei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-3266","authenticated-orcid":false,"given":"Peter","family":"Klivenyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2016.07.021_bib0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2016.07.021_bib0010","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease","volume":"2","author":"Zheng","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbr.2016.07.021_bib0015","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archneurol.2008.588","article-title":"PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia","volume":"66","author":"Qin","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbr.2016.07.021_bib0020","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/NEN.0b013e318275df4b","article-title":"Decreased mRNA expression of PGC-1alpha and PGC-1alpha-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS","volume":"71","author":"Thau","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbr.2016.07.021_bib0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF01799116","article-title":"Neuropathology and pathogenesis of mitochondrial diseases","volume":"19","author":"Brown","year":"1996","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbr.2016.07.021_bib0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/scdb.2001.0280","article-title":"Neuropathological features of mitochondrial disorders","volume":"12","author":"Tanji","year":"2001","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbr.2016.07.021_bib0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/B:NERE.0000014821.07269.8d","article-title":"Neuropathological aspects of mitochondrial DNA disease","volume":"29","author":"Betts","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2016.07.021_bib0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10540-007-9034-3","article-title":"Neuropathology of mitochondrial diseases","volume":"27","author":"Filosto","year":"2007","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbr.2016.07.021_bib0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1152\/physrev.00025.2007","article-title":"Transcriptional paradigms in mammalian mitochondrial biogenesis and function","volume":"88","author":"Scarpulla","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbr.2016.07.021_bib0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2016.07.021_bib0055","doi-asserted-by":"crossref","first-page":"498401","DOI":"10.1155\/2015\/498401","article-title":"Electron transport disturbances and neurodegeneration: from Albert Szent-Gyorgyi's concept (Szeged) till novel approaches to boost mitochondrial bioenergetics","volume":"2015","author":"Szalardy","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbr.2016.07.021_bib0060","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/hmg\/dds049","article-title":"Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse","volume":"21","author":"Dillon","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2016.07.021_bib0065","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/hmg\/ddp093","article-title":"PGC-1alpha\/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders","volume":"18","author":"Srivastava","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2016.07.021_bib0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice","volume":"119","author":"Lin","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2016.07.021_bib0075","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pbio.0030101","article-title":"PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis","volume":"3","author":"Leone","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbr.2016.07.021_bib0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2016.07.021_bib0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbr.2016.07.021_bib0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10571-014-0124-z","article-title":"mRNA expression levels of PGC-1alpha in a transgenic and a toxin model of Huntington's disease","volume":"35","author":"Torok","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2016.07.021_bib0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000346267","article-title":"Neuropathology of partial PGC-1alpha deficiency recapitulates features of mitochondrial encephalopathies but not of neurodegenerative diseases","volume":"12","author":"Szalardy","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.bbr.2016.07.021_bib0100","doi-asserted-by":"crossref","first-page":"e42878","DOI":"10.1371\/journal.pone.0042878","article-title":"Developmental alterations in motor coordination and medium spiny neuron markers in mice lacking pgc-1alpha","volume":"7","author":"Lucas","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2016.07.021_bib0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5114\/fn.2016.58911","article-title":"Histopathological comparison of Kearns-Sayre syndrome and PGC-1\u03b1-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy","volume":"54","author":"Szalardy","year":"2016","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.bbr.2016.07.021_bib0110","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00125-015-3671-z","article-title":"The hitchhiker's guide to PGC-1alpha isoform structure and biological functions","volume":"58","author":"Martinez-Redondo","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbr.2016.07.021_bib0115","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1093\/hmg\/ddt359","article-title":"Full-length PGC-1alpha salvages the phenotype of a mouse model of human neuropathy through mitochondrial proliferation","volume":"22","author":"Rona-Voros","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2016.07.021_bib0120","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1074\/jbc.M111.320200","article-title":"NT-PGC-1alpha protein is sufficient to link beta3-adrenergic receptor activation to transcriptional and physiological components of adaptive thermogenesis","volume":"287","author":"Chang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2016.07.021_bib0125","doi-asserted-by":"crossref","first-page":"30014","DOI":"10.1074\/jbc.M704817200","article-title":"Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals","volume":"282","author":"Handschin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2016.07.021_bib0130","doi-asserted-by":"crossref","first-page":"39087","DOI":"10.1074\/jbc.M110.151688","article-title":"Neuronal inactivation of peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) protects mice from diet-induced obesity and leads to degenerative lesions","volume":"285","author":"Ma","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2016.07.021_bib0135","first-page":"441","article-title":"Cerebellar transcriptional alterations with Purkinje cell dysfunction and loss in mice lacking PGC-1alpha","volume":"8","author":"Lucas","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbr.2016.07.021_bib0140","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","article-title":"Peroxisome-proliferator-activated receptor gamma coactivator 1 alpha contributes to dysmyelination in experimental models of Huntington's disease","volume":"31","author":"Xiang","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2016.07.021_bib0145","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/hmg\/dds177","article-title":"A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset","volume":"21","author":"Soyal","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2016.07.021_bib0150","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.wnr.0000073685.00308.89","article-title":"Assessing disease onset and progression in the SOD1 mouse model of ALS","volume":"14","author":"Weydt","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2016.07.021_bib0155","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00702-010-0573-6","article-title":"Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease","volume":"118","author":"Zadori","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbr.2016.07.021_bib0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbb.2015.03.002","article-title":"Central nervous system-specific alterations in the tryptophan metabolism in the 3-nitropropionic acid model of Huntington's disease","volume":"132","author":"Veres","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2016.07.021_bib0165","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0091-3057(91)90211-J","article-title":"Comparative behavioral and neurochemical studies with striatal kainic acid- or quinolinic acid-lesioned rats","volume":"39","author":"Vecsei","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2016.07.021_bib0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-4886(89)90170-2","article-title":"The quinolinic acid model of Huntington's disease: locomotor abnormalities","volume":"105","author":"Sanberg","year":"1989","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2016.07.021_bib0175","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3109\/15376516.2014.961216","article-title":"Piroxicam attenuates 3-nitropropionic acid-induced brain oxidative stress and behavioral alteration in mice","volume":"24","author":"C J","year":"2014","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.bbr.2016.07.021_bib0180","doi-asserted-by":"crossref","first-page":"e9793","DOI":"10.1371\/journal.pone.0009793","article-title":"Comprehensive behavioral testing in the R6\/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline","volume":"5","author":"Menalled","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2016.07.021_bib0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cmet.2005.03.002","article-title":"Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle","volume":"1","author":"Arany","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbr.2016.07.021_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005072-199301000-00001","article-title":"Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects","volume":"52","author":"Sparaco","year":"1993","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbr.2016.07.021_bib0195","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF00294616","article-title":"Neuropathology in Kearns-Sayre syndrome","volume":"80","author":"Oldfors","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2016.07.021_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.21211","article-title":"Localization of the transcriptional coactivator PGC-1alpha to GABAergic neurons during maturation of the rat brain","volume":"502","author":"Cowell","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbr.2016.07.021_bib0205","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2174\/1389202914666131210211033","article-title":"The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease","volume":"14","author":"Gaweda-Walerych","year":"2013","journal-title":"Curr. Genom."},{"key":"10.1016\/j.bbr.2016.07.021_bib0210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4093\/kdj.2010.34.3.146","article-title":"Adenine nucleotide translocator as a regulator of mitochondrial function: implication in the pathogenesis of metabolic syndrome","volume":"34","author":"Kim","year":"2010","journal-title":"Korean Diabetes J."},{"key":"10.1016\/j.bbr.2016.07.021_bib0215","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/CIRCRESAHA.114.302562","article-title":"A role for peroxisome proliferator-activated receptor gamma coactivator-1 in the control of mitochondrial dynamics during postnatal cardiac growth","volume":"114","author":"Martin","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbr.2016.07.021_bib0220","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/db05-0509","article-title":"Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2","volume":"55","author":"Soriano","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.bbr.2016.07.021_bib0225","first-page":"3","article-title":"Animal models for mitochondrial disease","volume":"197","author":"Wallace","year":"2002","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbr.2016.07.021_bib0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/5089","article-title":"Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression","volume":"21","author":"Wang","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbr.2016.07.021_bib0235","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ng0298-159","article-title":"A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase","volume":"18","author":"Melov","year":"1998","journal-title":"Nat. Genet."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816304491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816304491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T02:11:52Z","timestamp":1572660712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432816304491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":47,"alternative-id":["S0166432816304491"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2016.07.021","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of age-related clinical progression in PGC-1\u03b1-deficient mice \u2013 implications for mitochondrial encephalopathies","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2016.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}